Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Postmarket surveillance of arthroplasty device components using machine learning methods.

Cafri G, Graves SE, Sedrakyan A, Fan J, Calhoun P, de Steiger RN, Cuthbert A, Lorimer M, Paxton EW.

Pharmacoepidemiol Drug Saf. 2019 Aug 16. doi: 10.1002/pds.4882. [Epub ahead of print]

PMID:
31418506
2.

Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.

Parkhurst MR, Robbins PF, Tran E, Prickett TD, Gartner JJ, Jia L, Ivey G, Li YF, El-Gamil M, Lalani A, Crystal JS, Sachs A, Groh E, Ray S, Ngo LT, Kivitz S, Pasetto A, Yossef R, Lowery FJ, Goff SL, Lo W, Cafri G, Deniger DC, Malekzadeh P, Ahmadzadeh M, Wunderlich JR, Somerville RPT, Rosenberg SA.

Cancer Discov. 2019 Aug;9(8):1022-1035. doi: 10.1158/2159-8290.CD-18-1494. Epub 2019 Jun 4.

PMID:
31164343
3.

An international comparison of THA patients, implants, techniques, and survivorship in Sweden, Australia, and the United States.

Paxton EW, Cafri G, Nemes S, Lorimer M, Kärrholm J, Malchau H, Graves SE, Namba RS, Rolfson O.

Acta Orthop. 2019 Apr;90(2):148-152. doi: 10.1080/17453674.2019.1574395. Epub 2019 Feb 11.

4.

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.

Cafri G, Yossef R, Pasetto A, Deniger DC, Lu YC, Parkhurst M, Gartner JJ, Jia L, Ray S, Ngo LT, Jafferji M, Sachs A, Prickett T, Robbins PF, Rosenberg SA.

Nat Commun. 2019 Jan 25;10(1):449. doi: 10.1038/s41467-019-08304-z.

5.

Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.

Yossef R, Tran E, Deniger DC, Gros A, Pasetto A, Parkhurst MR, Gartner JJ, Prickett TD, Cafri G, Robbins PF, Rosenberg SA.

JCI Insight. 2018 Oct 4;3(19). pii: 122467. doi: 10.1172/jci.insight.122467.

6.

A review and empirical comparison of causal inference methods for clustered observational data with application to the evaluation of the effectiveness of medical devices.

Cafri G, Wang W, Chan PH, Austin PC.

Stat Methods Med Res. 2019 Oct-Nov;28(10-11):3142-3162. doi: 10.1177/0962280218799540. Epub 2018 Sep 11.

PMID:
30203707
7.

A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival.

Sharbi-Yunger A, Grees M, Cafri G, Bassan D, Eichmüller SB, Tzehoval E, Utikal J, Umansky V, Eisenbach L.

Int J Cancer. 2019 Feb 15;144(4):909-921. doi: 10.1002/ijc.31795. Epub 2018 Dec 5.

PMID:
30106470
8.

Survival and Reintervention Risk by Patient Age and Preoperative Abdominal Aortic Aneurysm Diameter after Endovascular Aneurysm Repair.

Hye RJ, Janarious AU, Chan PH, Cafri G, Chang RW, Rehring TF, Nelken NA, Hill BB.

Ann Vasc Surg. 2019 Jan;54:215-225. doi: 10.1016/j.avsg.2018.05.053. Epub 2018 Aug 4.

PMID:
30081171
9.

Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models.

Grees M, Sharbi-Yunger A, Evangelou C, Baumann D, Cafri G, Tzehoval E, Eichmüller SB, Offringa R, Utikal J, Eisenbach L, Umansky V.

Oncoimmunology. 2018 Mar 26;7(7):e1445457. doi: 10.1080/2162402X.2018.1445457. eCollection 2018.

10.

Meta-analysis of individual registry results enhances international registry collaboration.

Paxton EW, Mohaddes M, Laaksonen I, Lorimer M, Graves SE, Malchau H, Namba RS, Kärrholm J, Rolfson O, Cafri G.

Acta Orthop. 2018 Aug;89(4):369-373. doi: 10.1080/17453674.2018.1454383. Epub 2018 Mar 28.

11.

Increased Risk of ACL Revision With Soft Tissue Allografts: Response.

Maletis G, Inacio M, Love R, Cafri G, Funahashi T.

Am J Sports Med. 2018 Mar;46(4):NP4-NP5. doi: 10.1177/0363546518757688. No abstract available.

PMID:
29543515
12.

Midterm-Adjusted Survival Comparing the Best Performing Unicompartmental and Total Knee Arthroplasties in a Registry.

Bini SA, Cafri G, Khatod M.

J Arthroplasty. 2017 Nov;32(11):3352-3355. doi: 10.1016/j.arth.2017.05.050. Epub 2017 Jun 8.

PMID:
28803816
13.

Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.

Cafri G, Paxton EW, Chen Y, Cheetham CT, Gould MK, Sluggett J, Bini SA, Khatod M.

J Arthroplasty. 2017 Nov;32(11):3524-3528.e1. doi: 10.1016/j.arth.2017.05.042. Epub 2017 May 31.

PMID:
28634095
14.

Between-within effects in survival models with cross-classified clustering: Application to the evaluation of the effectiveness of medical devices.

Cafri G, Fan J.

Stat Methods Med Res. 2018 Jan;27(1):312-319. doi: 10.1177/0962280216628561. Epub 2016 Jul 20.

PMID:
28034173
15.

Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40.

Levin N, Pato A, Cafri G, Eisenberg G, Peretz T, Margalit A, Lotem M, Gross G.

J Immunother. 2017 Feb/Mar;40(2):39-50. doi: 10.1097/CJI.0000000000000150.

PMID:
28005579
16.

Bilateral Simultaneous vs Staged Total Knee Arthroplasty: A Comparison of Complications and Mortality.

Sheth DS, Cafri G, Paxton EW, Namba RS.

J Arthroplasty. 2016 Sep;31(9 Suppl):212-6. doi: 10.1016/j.arth.2016.03.018. Epub 2016 Mar 17.

PMID:
27430183
17.

Is There a Difference in Revision Risk Between Metal and Ceramic Heads on Highly Crosslinked Polyethylene Liners?

Cafri G, Paxton EW, Love R, Bini SA, Kurtz SM.

Clin Orthop Relat Res. 2017 May;475(5):1349-1355. doi: 10.1007/s11999-016-4966-1.

18.

Type and frequency of healthcare encounters can predict poor surgical outcomes in anterior cruciate ligament reconstruction patients.

Inacio MC, Cafri G, Funahashi TT, Maletis GB, Paxton EW.

Int J Med Inform. 2016 Jun;90:32-9. doi: 10.1016/j.ijmedinf.2016.03.005. Epub 2016 Mar 17.

PMID:
27103195
19.

Similar mortality with general or regional anesthesia in elderly hip fracture patients.

Brox WT, Chan PH, Cafri G, Inacio MC.

Acta Orthop. 2016;87(2):152-7. doi: 10.3109/17453674.2015.1128781. Epub 2016 Jan 11.

20.

An introduction and integration of cross-classified, multiple membership, and dynamic group random-effects models.

Cafri G, Hedeker D, Aarons GA.

Psychol Methods. 2015 Dec;20(4):407-21. doi: 10.1037/met0000043. Epub 2015 Aug 3.

21.

Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells.

Pato A, Eisenberg G, Machlenkin A, Margalit A, Cafri G, Frankenburg S, Merims S, Peretz T, Lotem M, Gross G.

Clin Exp Immunol. 2015 Nov;182(2):220-9. doi: 10.1111/cei.12688. Epub 2015 Aug 28.

22.

Meta-analysis of survival curve data using distributed health data networks: application to hip arthroplasty studies of the International Consortium of Orthopaedic Registries.

Cafri G, Banerjee S, Sedrakyan A, Paxton L, Furnes O, Graves S, Marinac-Dabic D.

Res Synth Methods. 2015 Dec;6(4):347-56. doi: 10.1002/jrsm.1159. Epub 2015 Jun 29.

PMID:
26123233
23.

mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity.

Cafri G, Sharbi-Yunger A, Tzehoval E, Alteber Z, Gross T, Vadai E, Margalit A, Gross G, Eisenbach L.

Mol Ther. 2015 Aug;23(8):1391-1400. doi: 10.1038/mt.2015.90. Epub 2015 May 22.

24.

Statistics in Brief: An Introduction to the Use of Propensity Scores.

Inacio MC, Chen Y, Paxton EW, Namba RS, Kurtz SM, Cafri G.

Clin Orthop Relat Res. 2015 Aug;473(8):2722-6. doi: 10.1007/s11999-015-4239-4. Epub 2015 Mar 13. No abstract available.

25.

Anterior and Anterolateral Approaches for THA Are Associated With Lower Dislocation Risk Without Higher Revision Risk.

Sheth D, Cafri G, Inacio MC, Paxton EW, Namba RS.

Clin Orthop Relat Res. 2015 Nov;473(11):3401-8. doi: 10.1007/s11999-015-4230-0.

26.

Revision total hip arthoplasty: factors associated with re-revision surgery.

Khatod M, Cafri G, Inacio MC, Schepps AL, Paxton EW, Bini SA.

J Bone Joint Surg Am. 2015 Mar 4;97(5):359-66. doi: 10.2106/JBJS.N.00073.

PMID:
25740025
27.

Is there a difference in total knee arthroplasty risk of revision in highly crosslinked versus conventional polyethylene?

Paxton EW, Inacio MC, Kurtz S, Love R, Cafri G, Namba RS.

Clin Orthop Relat Res. 2015 Mar;473(3):999-1008. doi: 10.1007/s11999-014-4046-3.

28.

Two-Day Length of Stay is Not Inferior to 3 Days in Total Knee Arthroplasty with Regards to 30-Day Readmissions.

Bini SA, Inacio MC, Cafri G.

J Arthroplasty. 2015 May;30(5):733-8. doi: 10.1016/j.arth.2014.12.006. Epub 2014 Dec 5.

PMID:
25550213
29.

International comparative evaluation of fixed-bearing non-posterior-stabilized and posterior-stabilized total knee replacements.

Comfort T, Baste V, Froufe MA, Namba R, Bordini B, Robertsson O, Cafri G, Paxton E, Sedrakyan A, Graves S.

J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:65-72. doi: 10.2106/JBJS.N.00462.

30.

International comparative evaluation of knee replacement with fixed or mobile non-posterior-stabilized implants.

Namba R, Graves S, Robertsson O, Furnes O, Stea S, Puig-Verdié L, Hoeffel D, Cafri G, Paxton E, Sedrakyan A.

J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:52-8. doi: 10.2106/JBJS.N.00466.

31.

Comparative effectiveness of ceramic-on-ceramic implants in stemmed hip replacement: a multinational study of six national and regional registries.

Sedrakyan A, Graves S, Bordini B, Pons M, Havelin L, Mehle S, Paxton E, Barber T, Cafri G.

J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:34-41. doi: 10.2106/JBJS.N.00465.

32.

Distributed analysis of hip implants using six national and regional registries: comparing metal-on-metal with metal-on-highly cross-linked polyethylene bearings in cementless total hip arthroplasty in young patients.

Furnes O, Paxton E, Cafri G, Graves S, Bordini B, Comfort T, Rivas MC, Banerjee S, Sedrakyan A.

J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:25-33. doi: 10.2106/JBJS.N.00459.

33.

Risk of revision following total hip arthroplasty: metal-on-conventional polyethylene compared with metal-on-highly cross-linked polyethylene bearing surfaces: international results from six registries.

Paxton E, Cafri G, Havelin L, Stea S, Pallisó F, Graves S, Hoeffel D, Sedrakyan A.

J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:19-24. doi: 10.2106/JBJS.N.00460.

34.

Effect of femoral head size on metal-on-HXLPE hip arthroplasty outcome in a combined analysis of six national and regional registries.

Allepuz A, Havelin L, Barber T, Sedrakyan A, Graves S, Bordini B, Hoeffel D, Cafri G, Paxton E.

J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:12-8. doi: 10.2106/JBJS.N.00461.

35.

A distributed health data network analysis of survival outcomes: the International Consortium of Orthopaedic Registries perspective.

Banerjee S, Cafri G, Isaacs AJ, Graves S, Paxton E, Marinac-Dabic D, Sedrakyan A.

J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:7-11. doi: 10.2106/JBJS.N.00642.

36.

Risk factors for total hip arthroplasty aseptic revision.

Khatod M, Cafri G, Namba RS, Inacio MC, Paxton EW.

J Arthroplasty. 2014 Jul;29(7):1412-7. doi: 10.1016/j.arth.2014.01.023. Epub 2014 Jan 25.

PMID:
24582159
37.

Increased risk of revision for high flexion total knee replacement with thicker tibial liners.

Namba RS, Inacio MC, Cafri G.

Bone Joint J. 2014 Feb;96-B(2):217-23. doi: 10.1302/0301-620X.96B2.32625.

PMID:
24493187
38.

Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.

Alteber Z, Azulay M, Cafri G, Vadai E, Tzehoval E, Eisenbach L.

Cancer Immunol Immunother. 2014 Apr;63(4):369-80. doi: 10.1007/s00262-014-1520-4. Epub 2014 Jan 23.

PMID:
24452202
39.

Surgeon, implant, and patient variables may explain variability in early revision rates reported for unicompartmental arthroplasty.

Bini S, Khatod M, Cafri G, Chen Y, Paxton EW.

J Bone Joint Surg Am. 2013 Dec 18;95(24):2195-202. doi: 10.2106/JBJS.L.01006.

PMID:
24352773
40.

Leadership, organizational climate, and working alliance in a children's mental health service system.

Green AE, Albanese BJ, Cafri G, Aarons GA.

Community Ment Health J. 2014 Oct;50(7):771-7. doi: 10.1007/s10597-013-9668-5. Epub 2013 Dec 10.

41.

Risk factors for total knee arthroplasty aseptic revision.

Namba RS, Cafri G, Khatod M, Inacio MC, Brox TW, Paxton EW.

J Arthroplasty. 2013 Sep;28(8 Suppl):122-7. doi: 10.1016/j.arth.2013.04.050. Epub 2013 Aug 15.

PMID:
23953394
42.

Alternative bearings in total knee arthroplasty: risk of early revision compared to traditional bearings: an analysis of 62,177 primary cases.

Inacio MC, Cafri G, Paxton EW, Kurtz SM, Namba RS.

Acta Orthop. 2013 Apr;84(2):145-52. doi: 10.3109/17453674.2013.784660. Epub 2013 Mar 14.

43.

Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulin.

Cafri G, Margalit A, Tzehoval E, Eisenbach L, Gross G.

Ann N Y Acad Sci. 2013 Apr;1283:87-90. doi: 10.1111/nyas.12017. Epub 2013 Feb 6. Review.

PMID:
23387369
44.

Production of LacZ inducible T cell hybridoma specific for human and mouse gp100₂₅₋₃₃ peptides.

Cafri G, Sharbi-Yunger A, Tzehoval E, Eisenbach L.

PLoS One. 2013;8(2):e55583. doi: 10.1371/journal.pone.0055583. Epub 2013 Feb 1.

45.

Parent predictors of child weight change in family based behavioral obesity treatment.

Boutelle KN, Cafri G, Crow SJ.

Obesity (Silver Spring). 2012 Jul;20(7):1539-43. doi: 10.1038/oby.2012.48. Epub 2012 Feb 23.

46.

Two novel treatments to reduce overeating in overweight children: a randomized controlled trial.

Boutelle KN, Zucker NL, Peterson CB, Rydell SA, Cafri G, Harnack L.

J Consult Clin Psychol. 2011 Dec;79(6):759-71. doi: 10.1037/a0025713.

47.

Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene.

Cafri G, Amram E, Rinott G, Koifman G, Fishman S, Keisari Y, Tzehoval E, Margalit A, Eisenbach L, Gross G.

Int Immunol. 2011 Jul;23(7):453-61. doi: 10.1093/intimm/dxr033. Epub 2011 Jun 7.

PMID:
21652516
48.

Parent-only treatment for childhood obesity: a randomized controlled trial.

Boutelle KN, Cafri G, Crow SJ.

Obesity (Silver Spring). 2011 Mar;19(3):574-80. doi: 10.1038/oby.2010.238. Epub 2010 Oct 21.

49.

Expanding the domains of attitudes towards evidence-based practice: the evidence based practice attitude scale-50.

Aarons GA, Cafri G, Lugo L, Sawitzky A.

Adm Policy Ment Health. 2012 Sep;39(5):331-40. doi: 10.1007/s10488-010-0302-3.

50.

Psychometric properties and U.S. National norms of the Evidence-Based Practice Attitude Scale (EBPAS).

Aarons GA, Glisson C, Hoagwood K, Kelleher K, Landsverk J, Cafri G.

Psychol Assess. 2010 Jun;22(2):356-65. doi: 10.1037/a0019188. Erratum in: Psychol Assess. 2010 Sep;22(3):701.

Supplemental Content

Support Center